Blog

Introduction

Ovarian cancer is known for its high recurrence rate and complex metastatic patterns, often involving lymph nodes, peritoneum, omentum, and distant sites. Accurate assessment of disease progression after surgery and chemotherapy is critical for guiding further oncologic management.

68Ga-FAPI PET-CT, a novel molecular imaging modality targeting cancer-associated fibroblasts, has shown superior sensitivity in detecting recurrent and metastatic ovarian cancer, especially in the peritoneum and lymph nodes.

This case highlights the clinical value of 68Ga-FAPI PET-CT in identifying disease progression in a treated ovarian cancer patient

Cancers of the oesophagogastric junction (OGJ) and proximal stomach are aggressive malignancies where accurate post-treatment assessment is critical for long-term outcomes. Conventional imaging may fail to differentiate residual disease from post-treatment changes.
⁶⁸Ga-FAPI PET-CT, a novel molecular imaging technique targeting cancer-associated fibroblasts, offers superior tumor visualization with low background uptake, making it highly effective in therapy response evaluation.

This case highlights the clinical value of ⁶⁸Ga-FAPI PET-CT in post-chemoradiation follow-up of OGJ carcinoma 

Introduction

Breast cancer remains one of the most common malignancies among women worldwide. Early detection and accurate staging play a crucial role in treatment planning and improving patient outcomes. F-18 FDG PET-CT scan has emerged as a powerful diagnostic tool that not only detects the primary tumor but also identifies nodal and distant metastases in a single whole-body evaluation.

This case demonstrates how FDG PET-CT changed the staging and management plan of a breast cancer patient, emphasizing its value as a one-stop solution in oncology.

By Dr. Rashmi Angadi – Nuclear Medicine Consultant, NeuMoD Digital PET-CT & Molecular Theranostics

Cancer care has come a long way, and at the heart of this transformation lies Nuclear Medicine—a powerful branch of medicine that merges diagnosis with treatment. In Hubballi, patients no longer need to travel to metro cities for cutting-edge cancer care. At NeuMoD Digital PET-CT & Molecular Theranostics, we bring world-class imaging and personalized cancer therapies to your doorstep.